Navigation Links
World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition


LOS ANGELES, CA (August 10, 2006) - DoveBid, Inc., (http://www.dovebid.com), the global leader in capital asset auction and valuation services, announced today it will be conducting its 50th global Life Sciences / BioPharma Exchange auction online, on August 15, 2006. The event marks a milestone for the DoveBid.com Life Sciences / BioPharma practice, and is expected to bring to-date total assets sold to over US$1 billion in original acquisition costs. Since the Life Sciences Industry Practice inception in 2003, DoveBid has dedicated global resources to bring best-in-class solutions to market supporting life science, pharmaceutical and healthcare industries.

The DoveBid Life Sciences / BioPharma Exchange enables organizations to proactively address asset management challenges in real time. DoveBid clients consign equipment from global locations and draw from DoveBid's portfolio of dedicated Marketing and Valuation solutions in order to bring the right buyers to the right assets at the right time. Global leaders participating in this program include Pfizer (NYSE:PFE), Bristol-Myers Squibb (NYSE:BMY), Procter & Gamble (NYSE:PG), Schering Corporation (NYSE:SGP), and mid-market competitors. "DoveBid's online Life Sciences marketplace and dedicated marketing deliver higher returns on surplus assets.

They understand our business, asset valuations and the global market for Life Sciences and Pharma equipment. We're seeing very positive results in asset disposition, redeployment and overall execution," said William Carr, Director of Global Sourcing for Pfizer Global R&D, Pfizer.

DoveBid offers both Self-service and Full-service, allowing global organ izations the choice of outsourcing the entire process, or building their own asset catalogues online, with enhanced ease of use guided selling capabilities. Through DoveBid's online industry auction exchanges, their assets immediately become visible to millions of buyers worldwide. DoveBid markets, sells, and manages the entire payment process, and provides access to global resources without the listing fees associated with consumer oriented online auction sites. Participants may bid online, review detailed asset descriptions, equipment catalogs, and online bidding instructions at www.dovebid.com.

"With over ten million capital asset transactions, DoveBid is the standard for valuation, management and disposition of global capital assets. The DoveBid portfolio of professional services and powerful web solutions deliver quantifiable value from the shop floor to the top floor," said Brent Cohen, CEO, DoveBid, Inc.


About DoveBid
DoveBid, Inc. is the global leader in capital asset management and valuation services, helping companies identify, redeploy and dispose of surplus assets through privately negotiated sales, live and online auctions, and industry specific web exchanges supporting key verticals and market segments. The Company provides strategic insight and valuation services for financial reporting, tax, secured lending and planning purposes.

Headquartered in Los Angeles, California, USA, DoveBid has over 67 years of industrial capital asset experience with more than 40 locations in 16 countries. More information on DoveBid can be found at www.dovebid.com or by contacting the company directly at (800) 665-1042 or (650) 571-7400.

DoveBid and the DoveBid logo are registered trademarks of DoveBid, Inc.

Contacts Americas: Asia Pacific: Europe/Middle East/Africa: Josh Prince
+1.650.377.2604
jprince@dovebid.com DoveBid, Inc.
10877 Wilshire Boulevard, Suite 600
Los Angeles, CA 90024, United States
Tel +1.310.775.6700
Fax +1.310.775.6800 DoveBid Singapore Pte Ltd
38 Mosque Street, Singapore 059518
Tel +65.63344266
Fax +65.63340469 DoveBid Trading France SARL
60 rue Marcel Dassault
92100 Boulogne Billancourt, France
Tel +33.(0).1.55.20.06.10
Tel +33.(0).1.55.20.06.11


back to top
'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. Preserve Samples for RNA Expression Microarrays RNAlater Around the World
2. RNAlater Around the World: The Art of Processing Difficult Samples
3. The Worlds Best DNase Improved TURBO DNA-free
4. RNase Activity in Mouse Tissue: Classification, Hierarchy, and Methods for Control
5. Advantages of Roche Applied Science amplification products
6. Tools for Proteomic Science II
7. Exploiting the Life Science Data Explosion to Speed New Drug Discovery
8. Automation of the Eppendorf Perfectprep BAC 96 DNA Kit on the Caliper Life Sciences Sciclone ALH 3000
9. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
10. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
11. National Instruments DIAdem -- Complete Your Technical Data Management Framework with Powerful Off-line Analysis, Visualization, and Report Generation
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. Hoffmann, ... faculty of the University of North Carolina Kenan-Flagler Business School effective ... at UNC Kenan-Flagler, with a focus on the school’s international efforts, leading classes ...
(Date:6/24/2016)... June 24, 2016  Regular discussions on a range of ... between the two entities said Poloz. Speaking at ... Ottawa , he pointed to the country,s inflation target, ... government. "In certain ... institutions have common economic goals, why not sit down and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in ... peritoneal or pleural mesothelioma. Their findings are the subject of a new article on ... biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients that ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology:
(Date:5/20/2016)... 2016  VoiceIt is excited to announce its ... By working together, VoiceIt and VoicePass will ... VoicePass take slightly different approaches to voice biometrics, ... and usability. ... partnership. "This marketing and technology partnership ...
(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
(Date:4/26/2016)... April 27, 2016 Research ... Multi-modal Biometrics Market 2016-2020"  report to their offering.  ... The analysts forecast the global multimodal ... 15.49% during the period 2016-2020.  Multimodal ... sectors such as the healthcare, BFSI, transportation, automotive, ...
Breaking Biology News(10 mins):